Exclusive

Publication

Byline

Location

US Patent Issued to Viridian Therapeutics on April 7 for "Compositions and methods for treatment of thyroid eye disease" (Massachusetts, Puerto Rico Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,309, issued on April 7, was assigned to Viridian Therapeutics Inc. (Waltham, Mass.). "Compositions and methods for treatment of thyroid eye... Read More


US Patent Issued to The Regents of the University of California on April 7 for "Compositions and methods for transferrin receptor 1 targeting" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,310, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.). "Compositions and methods for transf... Read More


US Patent Issued to The Regents of the University of California on April 7 for "Chimeric antigen receptors and related methods and compositions for the treatment of cancer" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,311, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.). "Chimeric antigen receptors and rela... Read More


US Patent Issued to The Governing Council of the University of Toronto, McMaster University on April 7 for "CD133-binding agents and uses thereof" (Canadian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,312, issued on April 7, was assigned to The Governing Council of the University of Toronto (Toronto) and McMaster University (Hamilton, Cana... Read More


US Patent Issued to Scancell on April 7 for "Modified Fc-regions to enhance functional affinity of antibodies and antigen binding fragments thereof" (British Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,313, issued on April 7, was assigned to Scancell Ltd. (Oxford, Great Britain). "Modified Fc-regions to enhance functional affinity of antib... Read More


US Patent Issued to R.P. Scherer Technologies on April 7 for "Antibody specific for GPC3 and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,314, issued on April 7, was assigned to R.P. Scherer Technologies LLC (Carson City, Nev.). "Antibody specific for GPC3 and methods of use t... Read More


US Patent Issued to S&T BIOMED on April 7 for "Monoclonal antibody of matrix metalloproteinase-1, detection kit and detection method thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,315, issued on April 7, was assigned to S&T BIOMED Co. LTD. (Zhubei City, Taiwan). "Monoclonal antibody of matrix metalloproteinase-1, dete... Read More


US Patent Issued to GENMAB on April 7 for "Bispecific and multispecific antibodies and method for isolation of such" (Dutch Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,316, issued on April 7, was assigned to GENMAB A/S (Valby, Denmark). "Bispecific and multispecific antibodies and method for isolation of s... Read More


US Patent Issued to Synaptive Medical on April 7 for "Liquid and agar fluorophore phantom" (Canadian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,317, issued on April 7, was assigned to Synaptive Medical Inc.. "Liquid and agar fluorophore phantom" was invented by Michael Frank Gunter ... Read More


US Patent Issued to MOCHIDA PHARMACEUTICAL on April 7 for "Crosslinked alginic acid" (Japanese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,318, issued on April 7, was assigned to MOCHIDA PHARMACEUTICAL Co. LTD. (Tokyo). "Crosslinked alginic acid" was invented by Shoji Furusako ... Read More